a public good project by the
Synthesis
Company
of California

© 2026

Richard B. Moss | doi.page

0 works0 citations0 h-index

Richard B. Moss

Stanford University(US)

Publications by Year

Research Areas

Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Asthma and respiratory diseases, Antifungal resistance and susceptibility, Tracheal and airway disorders

Most-Cited Works

→ A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation(2011)2,161 cited
→ Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria(2013)874 cited
→ Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation(2010)801 cited
→ Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference(2003)787 cited
→ Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial(1995)605 cited
→ Late Pulmonary Sequelae of Bronchopulmonary Dysplasia(1990)563 cited

→ Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation(2011)494 cited

→ Fungi and allergic lower respiratory tract diseases(2012)480 cited

→ Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis(2004)385 cited

→ Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis(2003)315 cited